By Rachel E. Gross from NYT Science https://ift.tt/vRlxWHP via IFTTT
Research shows why cancer stops responding to kinase-blocking drugs and comes back stronger
More than 70 FDA-approved cancer drugs are kinase inhibitors, which work by blocking kinases — enzymes that add phosphate groups to molecules in the cell — and preventing the chemical activity necessary for signaling and growth in cancer cells…
Read more at nsf.gov
More than 70 FDA-approved cancer drugs are kinase inhibitors, which work by blocking kinases — enzymes that add phosphate groups to molecules in the cell — and preventing the chemical activity necessary for signaling and growth in cancer cells…
Read more at nsf.gov
Comments
Post a Comment